Fig. 1. Effects of cumulative administration (upper , 0.2–0.4–0.6–0.8–1.2–1.6 mm) and bolus administration (lower , 0.6 mm) of enoximone on contracture development in two skeletal muscle specimens of this malignant hyperthermia–susceptible patient. For normal values, see table 1.